Ltd. to Further Strengthen DSA Supply Chain; Transaction Expected to be Accretive to Non-GAAP Earnings Per Share by Approximately $0.25 in 2026 and Approximately $0.60 in 2027 –– Exercises Option to ...
Vin Singh Founder and Chief Executive Officer BullFrog AI Holdings, Inc.
Preliminary 2025 total revenue of $672 million to $674 million, exceeding top end of guidance Preliminary cash and investments of approximately ...
The Business & Financial Times on MSN
Ghana Shippers’ Authority hosts exporters’ forum
The Ghana Shippers’ Authority (GSA) has held a high-level Exporters’ Forum aimed at strengthening collaboration among ...
The latest announcement is out from BullFrog AI Holdings, Inc. ( ($BFRG) ). In a December 30, 2025 letter to shareholders, BullFrog AI detailed a ...
Alignment Reached with U.S. FDA on Potential Accelerated Approval Pathway for BEAM-302 in Alpha-1 Antitrypsin Deficiency ...
Caris Life Sciences plans to report its complete fourth quarter and full year 2025 financial results during its earnings call ...
Genmab shifts to innovation-led growth with 21% revenue, 52% operating profit, $3.4B cash, Epkinly, Rina-S, and Anthropic AI ...
RVMD stays a Strong Buy as RAS inhibitor trials advance; phase 3 RASolute-302 is a key 2026 catalyst. Read the latest ...
In our latest interview, News-Medical speaks with Rosanna Zhang from ACROBiosystems about utilizing organoids for disease ...
The annual J.P. Morgan Healthcare Conference is officially underway, bringing the healthcare and biopharma industries' ...
Increased CARVYKTI® manufacturing capacity with the physical expansion of the Raritan facility, now the largest cell therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback